Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 195

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 195
---
 the foregoing clause (A) for purposes of the non-contravention representation or warranty made by Enfusion or the condition to Closing to the extent relating to such representation or                                              
 warranty;                                                                                                                                                                                                                                          |

| (C) | general business, economic or political conditions, or the capital, credit, banking, debt, financial or                                                                                       
 currency markets, in the United States or elsewhere in the world, or changes therein, including changes in interest or exchange rates or any suspension of trading in securities on the NYSE; |

| (D) | general conditions in any industry in which Enfusion and its subsidiaries operate or in any specific                                               
 jurisdiction or geographic area in the United States or elsewhere in the world in which Enfusion and its subsidiaries operate, or changes therein; |

| (E) | any changes in GAAP or other accounting standards (or the enforcement or interpretation thereof) enacted after 
 the date of the Merger Agreement;                                                                              |

| (F) | any changes in applicable law (or the enforcement or interpretation thereof), including the adoption,                                                                                                                                              
 implementation, repeal, modification, reinterpretation or proposal of any applicable law (or the enforcement or interpretation thereof) by any governmental authority, or any panel or advisory body empowered or appointed thereby, in each case, 
 enacted after the date of the Merger Agreement;                                                                                                                                                                                                    |

| (G) | the taking of any action, or refraining from taking any action, in each case at the express written direction 
 of Clearwater, Acquirer, Merger Sub or Merger Sub II or as expressly required by the Merger Agreement;        |

| (H) | any claim, demand, or other proceeding (including any class action or derivative litigation) asserted,                                                                                                                                          
 commenced or threatened by, on behalf of or in the name of, against or otherwise involving Enfusion, the Enfusion Board, any committee thereof and/or any of the Enfusion’s directors or officers relating directly or indirectly to the Merger 
 Agreement, the Transactions or any related transaction prior to the                                                                                                                                                                             |

124

| Effective Time or any demand or proceeding for appraisal or the fair value of any shares of Enfusion Common Stock and Enfusion Class B Common Stock pursuant to the DGCL in connection with 
 the Merger Agreement;                                                                                                                                                                       |

| (I) | any outbreak, continuation or escalation of acts of terrorism, hostilities, sabotage or war (whether or not                                                                                                                                                                                                                                                                                                                   
 declared, including the Russian-Ukrainian and Israeli-Palestinian conflicts, and